News | July 01, 2022
Jubilant HollisterStier announces CAD 100 mn for Montreal facility
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
Doctors will study for a Master of Surgery or Master of Medicine degree at Edge Hill University.
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
It´s the first trial to demonstrate the benefits of dual pathway inhibition
Subscribe To Our Newsletter & Stay Updated
